18 The role of AI and ML
AI has the potential to transform the future of the pharmaceutical industry. As datasets grow in number and diversity, the need for efficient and effective analysis is paramount, highlighting the significance of AI and ML technologies. AI can analyse masses of data, in a fraction of the time of conventional approaches without the risk of human error. These tools can be used to accelerate the prediction and optimisation of experiments, quickly identify anomalies, and empower decision-making.
Adequately engineered, quality data and an infrastructure for facile data management are key factors in the successful implementation of AI in pharmaceutical workflows. The maximal potential of AI can only be achieved if it is properly trained with good-quality datasets. Implementation and integration of appropriate chemistry software tools, like Method Selection Suite, can help create comprehensive and curated databases that can be used to supplement AI tools.
The software prepares data for machine use by homogenising and storing it with its chemical context - further enabling integration into AI initiatives by exporting the data in machine- readable format (i.e., JSON) ready for AI and ML applications.
Conclusion
Data analysis software tools are increasingly being leveraged to integrate and manage the vast amounts of data generated by pharmaceutical organisations, helping to eliminate siloed systems and empowering data accessibility. With the correct digital tools, collaboration is easier and scientists can preserve and leverage knowledge for future projects, data science, and deeper insights.
Digital transformation offers pharmaceutical organisations great potential. When done right, it should enhance processes to efficiently collect, analyse, and manage data, offer greater accessibility of data, and ensure that value can be extracted from the data to support informed data-driven decision-making.
Read, Share and Comment on this Article, visit:
www.labmate-online.com Continuous validation of HPLC performance in regulated laboratories
Testa Analytical announces the successful completion of extensive testing for its flowmeter software driver designed for chromatography data systems (CDS) in a regulated pharmaceutical laboratory environment.
Robust testing of new software packages and drivers is a crucial aspect of any product release, particularly when the software is intended to seamlessly interface with chromatography software packages from various HPLC and GPC/SEC manufacturers.
Jeanette Ziemba, Technical Manager at Testa Analytical, stated: “Our new flowmeter software driver, after comprehensive in-house testing, underwent extensive evaluation in a leading European pharmaceutical lab. Managing a diverse range of HPLC instruments with different chromatography data systems in a tightly regulated client-server environment, the
lab was pleased with how the software driver facilitated easy acquisition and traceable logging of flow data from all its liquid chromatographs. The software’s capability to support multiple Flowmeters connected to different HPLC systems in both analytical and semi-prep applications significantly streamlines tasks.”
She further explained: “The ability to save real-time flow rate data with each chromatogram is a valuable tool for comprehensive quality assessment of any HPLC, UHPLC, LC/MS, or GPC/SEC system. The software driver, built on
rc.NET technology, ensures cross-platform connectivity of all Testa Analytical flowmeters to Chromatography Data System software packages, including OpenLab (Agilent Corp), Clarity Chromatography Software (DataApex), Empower (Waters Corp), LabSolutions (Shimadzu Corp), and WinGPC Software (Agilent).”
Ms Ziemba concluded: “The capability to collect and store real-time flow rate data, along with chromatography detector signals, not only enhances quality assessment but also provides continuous validation of compliance with the planned chromatographic separation method. In essence, this affordable flowmeter software driver complements and extends the capabilities of any modern liquid chromatography software package.”
More information online:
ilmt.co/PL/EVbj 62239pr@reply-direct.com Bigger
More content, more readers, more media platforms.
Faster Smarter
Content added and updated daily.
Available via our app on your smart phone or tablet.
Print, Online andDigital Media combined to reach 500,000 readers* *Average Pass-on rate = 3.2
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148
